Martin E Gutierrez, MD
Cancer Genetics, Gastrointestinal Medical Oncology, Thoracic Medical Oncology
New patient visits
Dr. Gutierrez is a medical oncologist who specializes in the care of patients with lung cancer and digestive cancers, such as colon cancer. As a renowned investigator, he leads John Theurer Cancer Center's Phase I clinical trials program and other early-stage cancer research, bringing the most promising investigational treatments to patients during their earliest stages of evaluation. In his research, he is committed to developing new therapies for solid tumors that could enhance patient outcomes.
Provider Information
Specialties
Cancer Genetics
Gastrointestinal Medical Oncology
Thoracic Medical Oncology
Gender
Male
Languages
English
Spanish
Age groups seen
Adults
Adults Over 65
Education
Other
Medical School
National Institutes of Health, NIH
Boston University Medical Center
Boston University Medical Center
Certifications
Medical Oncology - American Board of Internal Medicine - 2022
Internal Medicine - American Board of Internal Medicine - 2022
Conditions Treated
immunochemotherapy
cancer immunotherapy
egfr mutation
clinical trials
lung lesions
adenocarcinoma of lung
squamous cancer of the lung
metastatic tumors to the lungs
lung metastasis
small cell lung cancer
sarcoma of the lung
pulmonary nodule
non small cell lung cancer
lung cancer genomics
lung cancer
large cell cancer of the lung
asbestos lung
alk translocation
egfr translocation
gastrointestinal cancer genetic syndromes
gastric adenocarcinoma
gallbladder cancer chemotherapy
frasier syndrome
family history of colon cancer
familial medullary thyroid cancer
familial intestinal gastric cancer
esophageal mass
esophageal cancer chemotherapy
diaphragmatic tumor
diaphragm cancer
denys drash syndrome (dds)
cystic pancreatic neuroendocrine tumors
colorectal metastases
colorectal cancer chemotherapy
chylous mass
chylous effusion
cardiotoxicity
cardiac tumor
cancer risk
cancer predisposition syndromes
bullous emphysema
breast ovarian pancreatic cancer syndrome
breast cancer genetics
braf v600e v600k mutations
biliary tract cancer chemotherapy
appendiceal mucocele
appendiceal carcinoid
appendiceal cancer chemotherapy
appendiceal adenocarcinoma
anorectal cancer chemotherapy
anal cancer chemotherapy
adolescent and young adult cancer (aya)
abdominal cancer chemotherapy
abdominal cancer
immunochemotherapy
cancer immunotherapy
egfr mutation
clinical trials
lung lesions
adenocarcinoma of lung
squamous cancer of the lung
metastatic tumors to the lungs
lung metastasis
small cell lung cancer
sarcoma of the lung
pulmonary nodule
non small cell lung cancer
lung cancer genomics
lung cancer
large cell cancer of the lung
asbestos lung
genetic cancer risk assessment
rps20 gene
rnf43 gene
vhl gene
tmem127 gene
sufu gene
smarcb1 gene
smarca4 gene
smad4 gene
sdhd gene
sdhc gene
sdhb gene
sdhaf2 gene
sdha gene
rb1 gene
rad51d gene
rad51c gene
rad50 gene
ptch1 gene
pole gene
pold1 gene
pms2 gene
pdgfra gene
nthl1 gene
nbn gene
mutyh gene
msh6 gene
msh3 gene
msh2 gene
mre11a gene
mlh1 gene
max gene
mitf gene
met gene
kit gene
hoxb13 gene
grem1 gene
galnt12 gene
cdk4 gene
flcn gene
epcam gene
dicer1 gene
cdkn2a gene
cdh13 gene
bmpr1a gene
bard1 gene
bap1 gene
axin2 gene
apc gene
hereditary cancer gene panel
pten hamartoma tumor syndrome
palb2
atm mutation
pten
p53
checkpoint kinase 2
cancer syndromes
panel genetic testing
hereditary cancer risk
genomics
cancer genomics
breast cancer genetic testing
thoracic cancer
pulmonary carcinoid
adenoid cystic carcinoma
tracheal cancer
thoracic malignancy
thymus cancer
thymoma
pleural cancer
mesothelioma
malignant effusion
chest wall tumors
mediastinum cancer
alk translocation
breast cancer immunotherapy
malignant carcinoid tumor of colon
stomach cancer
targeted molecular therapy
malignant gallbladder polyp
gallbladder mass
duodenal mass
ampullary mass
hereditary colon cancer
metastatic pancreatic cancer
malignant carcinoid tumor of the stomach
malignant carcinoid tumor of the esophagus
squamous cell carcinoma of the esophagus
neuroendocrine tumor of the gallbladder
neuroendocrine tumor of the extrahepatic bile ducts
small intestine cancer
abdominal chemotherapy
esophageal cancer
hepatobiliary malignancies
spleen cancer
small bowel cancer
recurrent colorectal cancer
pseudomyxoma peritonei
pancreatic mass
pancreas cancer
pancreas tail cancer
pancreas head cancer
neuroendocrine tumors
neuroendocrine tumor of the pancreas
metastatic colon cancer
malignant tumor of extrahepatic bile duct
malignant rectal neoplasm
malignant neoplasm of pancreatic duct
gallbladder cancer
malignant carcinoid tumor of rectum
liver mass
islet cell tumor
insulinoma
lynch syndrome
hepatoblastoma
gastrointestinal (gi) stromal tumors
gastrointestinal (gi) cancer
gastrin secreting tumor of pancreas
egfr translocation
cystadenoma of pancreas
colon cancer chemotherapy
carcinoid tumor of pancreas
carcinoid tumor
carcinoid of stomach
gastroesophageal junction cancer
cholangiocarcinoma
appendiceal cancer
rectal carcinoma in situ
rectal cancer
anorectal cancer
anal cancer
colorectal malignancy
chemoradiation
wilms tumor 1 mutations
vkorc1 mutation
tsc2 gene
tsc1 gene
thoracic oncology
stomach cancer chemotherapy
spleen cancer chemotherapy
small intestine tumors
small intestine cancer chemotherapy
small cell lung cancer chemotherapy
rib cancer
rat sarcoma oncogenes mutation
pulmonary lung nodule diagnostics
pseudopapillary tumors
proto-oncogene b-raf and v-raf murine sarcoma viral oncogene homolog b mutation
primary mediastinal goiter
pneumomediastinum
pleural cancer chemotherapy
personal history of malignant neoplasm of liver
peritoneal carcinomatosis
pediatric cancer predisposition
pancreatic cancer chemotherapy
ntric fusion mutation
neuroendocrine tumor of the lung
met proto-oncogene receptor tyrosine kinase mutation
mesothelioma thymic carcinoma
men1 genetic testing
men1 gene
malignant lung tumors
liver-directed therapy for neuroendocrine tumors
liver cancer chemotherapy
liver cancer
liquid biopsy testing
intrapleural chemotherapy
intra abdominal cancer
intestinal metaplasia
intestinal cancer
hyperthermic intraperitoneal chemotherapy (hipec)
human epidural growth factor 2 mutation
hras mutation
hormone receptor positive breast cancer
hilar cholangiocarcinoma
high risk cancer surveillance
hereditary retinoblastoma
hereditary breast and ovarian cancer
her2 positive breast cancer
gastrointestinal management with neuroendocrine tumors
Virtual care available
For COVID-19 symptoms/testing, fever, cough, colds, UTI, allergies and more.
Self-pay or Insurance
